Current Status of Cardiac Xenotransplantation: Report of a Workshop of the German Heart Transplant Centers, Martinsried, March 3, 2023

 

 Buy Article Permissions and Reprints All articles of this category

Abstract

This report comprises the contents of the presentations and following discussions of a workshop of the German Heart Transplant Centers in Martinsried, Germany on cardiac xenotransplantation. The production and current availability of genetically modified donor pigs, preservation techniques during organ harvesting, and immunosuppressive regimens in the recipient are described. Selection criteria for suitable patients and possible solutions to the problem of overgrowth of the xenotransplant are discussed. Obviously microbiological safety for the recipient and close contacts is essential, and ethical considerations to gain public acceptance for clinical applications are addressed. The first clinical trial will be regulated and supervised by the Paul-Ehrlich-Institute as the National Competent Authority for Germany, and the German Heart Transplant Centers agreed to cooperatively select the first patients for cardiac xenotransplantation.

List of Participants

Abteilung für Herzchirurgie, Kerckhoff-Klinik GmbH Bad Nauheim -

Prof. Dr. Yeong-Hoon Choi

Dr. Nemanja Zukic

Klinik für Thorax- und kardiovaskuläre Chirurgie, Herz und Diabeteszentrum Bad Oeynhausen

Prof. Dr. Jan Gummert

Prof. Dr. René Schramm

Deutsches Herzzentrum der Charité Berlin

Prof. Dr. Christoph Knosalla

Freie Universität Berlin

Dr. Joachim Denner

Herzzentrum Dresden

Dr. Stefan Brose

Prof. Dr. Sems Malte Tugtekin

Pascal Tugtekin

Klinik für Herzchirurgie, Universitätsklinikum Düsseldorf

Prof. Dr. Artur Lichtenberg

Prof. Dr. Udo Boeken

Herzchirurgische Klinik, Uniklinikum Erlangen

Prof. Dr. Christian Heim

Kinderherzchirurgische Abteilung, Uniklinikum Erlangen

Prof. Dr. Oliver Dewald

Dr. Ariawan Purbojo

Klinik für Thorax- und kardiovaskuläre Chirurgie, Universitätsmedizin Essen

Prof. Dr. Arjang Ruhparwar (seit 01.04.2023 Klinik für Herz-, Thorax-, Transplantationschirurgie, Medizinische Hochschule Hannover)

PD Dr. Bastian Schmack (seit 01.04.2023 Klinik für Herz-, Thorax-, Transplantationschirurgie, Medizinische Hochschule Hannover)

Universitäts-Herzzentrum Freiburg/Bad Krozingen

Prof. Dr. Martin Czerny

PD Dr. David Schibilsky

Klinik für Herz-, Thorax- und Gefäßchirurgie, Universitätsmedizin Göttingen

Prof. Dr. Ingo Kutschka

Klinik für Herz- und Gefäßchirurgie, Universitätsklinikum Hamburg-Eppendorf

Prof. Dr. Hermann Reichenspurner

PD Dr. Alexander Bernhard

Klinik und Poliklinik für Kinderherzmedizin und EMAH, Universitätsklinikum Hamburg-Eppendorf

Prof. Dr. Michael Hübler

Dr. Samira Hübler

Klinik für Herz-, Thorax-, Transplantations- und Gefäßchirurgie, Medizinische Hochschule Hannover

Prof. Dr. Axel Haverich

Dr. Tobias Goecke

Klinik für Herzchirurgie, Universitätsklinikum Heidelberg

PD Dr. Rawa Arif

Klinik für Herz- und Thoraxchirurgie, Universitätsklinikum Jena

Prof. Dr. Torsten Doenst

PD Dr. Gloria Färber

Klinik für Herz- und Gefäßchirurgie, Universitätsklinikum Schleswig-Holstein, Campus Kiel

Prof. Dr. Jochen Cremer

Prof. Dr. Assad Haneya

Paul-Ehrlich Institut, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel, Langen

Prof. Dr. Ralf Reinhard Tönjes

Herzzentrum Leipzig

Dr. Uwe Schulz

Klinikum der Universität München

Prof. Dr. Christian Hagl

Prof. Dr. Michael Schmoeckel

Prof. Dr. Bruno Reichart

PD Dr. Matthias Längin

PD Dr. Jan-Michael Abicht

Dr. Michael Bender

Prof. Dr. Paolo Brenner

Dr. Carola Grinninger

Dr. Christine-Elena Kamla

Prof. Dr. Georg Marckmann

Prof. Dr. Sebastian Michel

Dr. Daniel Reichart

Reinhard Ellgass

Genzentrum und Centre for Innovative Medical Models (CiMM) der LMU München

Prof. Dr. Eckhard Wolf

Prof. Dr. Elisabeth Kempter

Dr. Barbara Keßler

Granzer Regulatory Consulting & Services, München

Dr. Stefan Blesse

Klinik und Poliklinik für Herz-, Thorax- und herznahe Gefäßchirurgie, Universitätsklinikum Regensburg

Prof. Dr. Christof Schmid

PD Dr. Simon Schopka

Publication History

Received: 25 September 2023

Accepted: 22 November 2023

Accepted Manuscript online:
28 December 2023

Article published online:
12 February 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J 2021; 42 (06) 681-683
  Google Scholar
• 2 Ruck JM, Zhou AL, Zeiser LB. et al. Trends and three-year outcomes of hepatitis C virus-viremic donor heart transplant for hepatitis C virus-seronegative recipients. JTCVS Open 2022; 12: 269-279
  Google Scholar
• 3 Ayer A, Schroder JN, Casalinova S. et al. The future of heart procurement with donation after circulatory death: current practice and opportunities for advancement. J Heart Lung Transplant 2022; 41 (10) 1385-1390
  Google Scholar
• 4 Joshi Y, Scheuer S, Chew H. et al. Heart transplantation from DCD donors in Australia: lessons learned from the first 74 cases. Transplantation 2023; 107 (02) 361-371
  Google Scholar
• 5 Messer S, Rushton S, Simmonds L. et al. A national pilot of donation after circulatory death (DCD) heart transplantation within the United Kingdom. J Heart Lung Transplant 2023; 42 (08) 1120-1130
  Google Scholar
• 6 Yuzefpolskaya M, Schroeder SE, Houston BA. et al. The Society of Thoracic Surgeons Intermacs 2022 Annual Report: focus on the 2018 heart transplant allocation system. Ann Thorac Surg 2023; 115 (02) 311-327
  Google Scholar
• 7 Längin M, Mayr T, Reichart B. et al. Consistent success in life-supporting porcine cardiac xenotransplantation. Nature 2018; 564 (7736) 430-433
  Google Scholar
• 8 Reichart B, Längin M, Radan J. et al. Pig-to-non-human primate heart transplantation: the final step toward clinical xenotransplantation?. J Heart Lung Transplant 2020; 39 (08) 751-757
  Google Scholar
• 9 Litovsky SH, Foote JB, Jagdale A. et al. Cardiac and pulmonary histopathology in baboons following genetically-engineered pig orthotopic heart transplantation. Ann Transplant 2022; 27: e935338
  Google Scholar
• 10 Mohiuddin MM, Goerlich CE, Singh AK. et al. Progressive genetic modifications of porcine cardiac xenografts extend survival to 9 months. Xenotransplantation 2022; 29 (03) e12744
  Google Scholar
• 11 Griffith BP, Goerlich CE, Singh AK. et al. Genetically modified porcine-to-human cardiac xenotransplantation. N Engl J Med 2022; 387 (01) 35-44
  Google Scholar
• 12 Mohiuddin MM, Singh AK, Scobie L. et al. Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report. Lancet 2023; 402 (10399): 397-410
  Google Scholar
• 13 Moazami N, Stern JM, Khalil K. et al. Pig-to-human heart xenotransplantation in two recently deceased human recipients. Nat Med 2023; 29 (08) 1989-1997
  Google Scholar
• 14 Novitzky D. Electrocardiographic, hemodynamic and endocrine changes occurring during experimental brain death in the Chacma baboon. J Heart Transplant 1984; 4: 63-69
  Google Scholar
• 15 Bery A, Marklin G, Itoh A. et al. Specialized donor care facility model and advances in management of thoracic organ donors. Ann Thorac Surg 2022; 113 (06) 1778-1786
  Google Scholar
• 16 Cooper DKC, Hara H. Xenotransplantation—a basic science perspective. Kidney360 2023; 4 (08) 1147-1149
  Google Scholar
• 17 Byrne GW, McGregor CG. Cardiac xenotransplantation: progress and challenges. Curr Opin Organ Transplant 2012; 17 (02) 148-154
  Google Scholar
• 18 Sykes M, Sachs DH. Transplanting organs from pigs to humans. Sci Immunol 2019; 4 (41) eaau6298
  Google Scholar
• 19 Phelps CJ, Koike C, Vaught TD. et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299 (5605) 411-414
  Google Scholar
• 20 Kwon DN, Lee K, Kang MJ. et al. Production of biallelic CMP-Neu5Ac hydroxylase knock-out pigs. Sci Rep 2013; 3: 1981
  Google Scholar
• 21 Lutz AJ, Li P, Estrada JL. et al. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose α-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 2013; 20 (01) 27-35
  Google Scholar
• 22 Estrada JL, Martens G, Li P. et al. Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes. Xenotransplantation 2015; 22 (03) 194-202
  Google Scholar
• 23 Diamond LE, Quinn CM, Martin MJ, Lawson J, Platt JL, Logan JS. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 2001; 71 (01) 132-142
  Google Scholar
• 24 Cozzi E, White DJG. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1 (09) 964-966
  Google Scholar
• 25 Fodor WL, Williams BL, Matis LA. et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci U S A 1994; 91 (23) 11153-11157
  Google Scholar
• 26 Galli C. Animal engineering for xenotransplantation: genome editing and cloning in pigs for xenotransplantation. EJT 2023; 1 (03) 182-191
  Google Scholar
• 27 Cowan PJ, Robson SC. Progress towards overcoming coagulopathy and hemostatic dysfunction associated with xenotransplantation. Int J Surg 2015; 23 (Pt B): 296-300
  Google Scholar
• 28 Pierson III RN, Fishman JA, Lewis GD. et al. Progress toward cardiac xenotransplantation. Circulation 2020; 142 (14) 1389-1398
  Google Scholar
• 29 Wuensch A, Baehr A, Bongoni AK. et al. Regulatory sequences of the porcine THBD gene facilitate endothelial-specific expression of bioactive human thrombomodulin in single- and multitransgenic pigs. Transplantation 2014; 97 (02) 138-147
  Google Scholar
• 30 Iwase H, Ekser B, Satyananda V. et al. Pig-to-baboon heterotopic heart transplantation–exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens. Xenotransplantation 2015; 22 (03) 211-220
  Google Scholar
• 31 Shu S, Ren J, Song J. Cardiac xenotransplantation: a promising way to treat advanced heart failure. Heart Fail Rev 2022; 27 (01) 71-91
  Google Scholar
• 32 Mohiuddin MM, Reichart B, Byrne GW, McGregor CGA. Current status of pig heart xenotransplantation. Int J Surg 2015; 23 (Pt B): 234-239
  Google Scholar
• 33 Steen S, Paskevicius A, Liao Q, Sjöberg T. Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours. Scand Cardiovasc J 2016; 50 (03) 193-200
  Google Scholar
• 34 Längin M, Reichart B, Steen S. et al. Cold non-ischemic heart preservation with continuous perfusion prevents early graft failure in orthotopic pig-to-baboon xenotransplantation. Xenotransplantation 2021; 28 (01) e12636
  Google Scholar
• 35 Bühler L, Basker M, Alwayn IP. et al. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000; 70 (09) 1323-1331
  Google Scholar
• 36 Samy KP, Butler JR, Li P, Cooper DKC, Ekser B. The role of costimulation blockade in solid organ and islet xenotransplantation. J Immunol Res 2017; 2017: 8415205
  Google Scholar
• 37 Reichart B, Längin M, Denner J, Schwinzer R, Cowan PJ, Wolf E. Pathways to clinical cardiac xenotransplantation. Transplantation 2021; 105 (09) 1930-1943
  Google Scholar
• 38 Längin M, Buttgereit I, Reichart B. et al. Xenografts show signs of concentric hypertrophy and dynamic left ventricular outflow tract obstruction after orthotopic pig-to-baboon heart transplantation. Transplantation 2023; 107 (12) e328-e338
  Google Scholar
• 39 Soin B, Ostlie D, Cozzi E. et al. Growth of porcine kidneys in their native and xenograft environment. Xenotransplantation 2000; 7 (02) 96-100
  Google Scholar
• 40 Tanabe T, Watanabe H, Shah JA. et al. Role of intrinsic (graft) versus extrinsic (host) factors in the growth of transplanted organs following allogeneic and xenogeneic transplantation. Am J Transplant 2017; 17 (07) 1778-1790
  Google Scholar
• 41 Arrunátegui AM, Ramón DS, Viola LM, Olsen LG, Jaramillo A. Technical and clinical aspects of the histocompatibility crossmatch assay in solid organ transplantation. Biomédica 2022; 42 (02) 391-413
  Google Scholar
• 42 Guillaume N. Improved flow cytometry crossmatching in kidney transplantation. HLA 2018; 92 (06) 375-383
  Google Scholar
• 43 Porrett PM, Orandi BJ, Kumar V. et al. First clinical-grade porcine kidney xenotransplant using a human decedent model. Am J Transplant 2022; 22 (04) 1037-1053
  Google Scholar
• 44 Wekerle T, Segev D, Lechler R, Oberbauer R. Strategies for long-term preservation of kidney graft function. Lancet 2017; 389 (10084): 2152-2162
  Google Scholar
• 45 Ansari D, Bućin D, Nilsson J. Human leukocyte antigen matching in heart transplantation: systematic review and meta-analysis. Transpl Int 2014; 27 (08) 793-804
  Google Scholar
• 46 Ladowski JM, Houp J, Hauptfeld-Dolejsek V, Javed M, Hara H, Cooper DKC. Aspects of histocompatibility testing in xenotransplantation. Transpl Immunol 2021; 67: 101409
  Google Scholar
• 47 Galili U. Discovery of the natural anti-Gal antibody and its past and future relevance to medicine. Xenotransplantation 2013; 20 (03) 138-147
  Google Scholar
• 48 Padler-Karavani V, Varki A. Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation 2011; 18 (01) 1-5
  Google Scholar
• 49 Byrne GW, Stalboerger PG, Du Z, Davis TR, McGregor CG. Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation. Transplantation 2011; 91 (03) 287-292
  Google Scholar
• 50 Martens GR, Reyes LM, Li P. et al. Humoral reactivity of renal transplant-waitlisted patients to cells from GGTA1/CMAH/B4GalNT2, and SLA Class I knockout pigs. Transplantation 2017; 101 (04) e86-e92
  Google Scholar
• 51 Cooper DKC, Hara H, Iwase H. et al. Justification of specific genetic modifications in pigs for clinical organ xenotransplantation. Xenotransplantation 2019; 26 (04) e12516
  Google Scholar
• 52 Ladowski J, Martens G, Estrada J, Tector M, Tector J. The desirable donor pig to eliminate all xenoreactive antigens. Xenotransplantation 2019; 26 (04) e12504
  Google Scholar
• 53 Ladowski JM, Martens GR, Reyes LM. et al. Examining the biosynthesis and xenoantigenicity of Class II swine leukocyte antigen proteins. J Immunol 2018; 200 (08) 2957-2964
  Google Scholar
• 54 Ladowski JM, Hara H, Cooper DKC. The role of SLAs in xenotransplantation. Transplantation 2021; 105 (02) 300-307
  Google Scholar
• 55 He S, Li T, Feng H. et al. Incidence of serum antibodies to xenoantigens on triple-knockout pig cells in different human groups. Xenotransplantation 2023; (e-pub ahead of print). DOI: 10.1111/xen.12818.
  Google Scholar
• 56 Ladowski JM, Reyes LM, Martens GR. et al. Swine leukocyte antigen Class II is a xenoantigen. Transplantation 2018; 102 (02) 249-254
  Google Scholar
• 57 Martens GR, Ladowski JM, Estrada J. et al. HLA Class I-sensitized renal transplant patients have antibody binding to SLA Class I epitopes. Transplantation 2019; 103 (08) 1620-1629
  Google Scholar
• 58 Fischer K, Rieblinger B, Hein R. et al. Viable pigs after simultaneous inactivation of porcine MHC class I and three xenoreactive antigen genes GGTA1, CMAH and B4GALNT2. Xenotransplantation 2020; 27 (01) e12560
  Google Scholar
• 59 Fu R, Fang M, Xu K. et al. Generation of GGTA1-/-β2M-/-CIITA-/- pigs using CRISPR/Cas9 technology to alleviate xenogeneic immune reactions. Transplantation 2020; 104 (08) 1566-1573
  Google Scholar
• 60 Ladowski JM, Martens GR, Reyes LM, Hauptfeld-Dolejsek V, Tector M, Tector J. Examining epitope mutagenesis as a strategy to reduce and eliminate human antibody binding to class II swine leukocyte antigens. Immunogenetics 2019; 71 (07) 479-487
  Google Scholar
• 61 Denner J. Virus safety of xenotransplantation. Viruses 2022; 14: 1926
  Google Scholar
• 62 Denner J. The porcine virome and xenotransplantation. Virol J 2017; 14 (01) 171
  Google Scholar
• 63 Denner J. Zoonosis and xenozoonosis in xenotransplantation: A proposal for a new classification. Zoonoses Public Health 2023; 70 (06) 578-579
  Google Scholar
• 64 Denner J, Schuurman HJ, Patience C. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes–chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses. Xenotransplantation 2009; 16 (04) 239-248
  Google Scholar
• 65 Meng XJ. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet Microbiol 2010; 140 (3-4(: 256-265
  Google Scholar
• 66 Denner J. Xenotransplantation and hepatitis E virus. Xenotransplantation 2015; 22 (03) 167-173
  Google Scholar
• 67 Denner J, Bigley TM, Phan TL, Zimmermann C, Zhou X, Kaufer BB. Comparative analysis of Roseoloviruses in humans, pigs, mice, and other species. Viruses 2019; 11 (12) 1108
  Google Scholar
• 68 Kotton CN, Torre-Cisneros J, Aguado JM. et al; International CMV Symposium Faculty. Cytomegalovirus in the transplant setting: where are we now and what happens next? A report from the International CMV Symposium 2021. Transpl Infect Dis 2022; 24 (06) e13977
  Google Scholar
• 69 Denner J. Reduction of the survival time of pig xenotransplants by porcine cytomegalovirus. Virol J 2018; 15 (01) 171
  Google Scholar
• 70 Denner J, Längin M, Reichart B. et al. Impact of porcine cytomegalovirus on long-term orthotopic cardiac xenotransplant survival. Sci Rep 2020; 10 (01) 17531
  Google Scholar
• 71 Denner J, Schuurman HJ. Early testing of porcine organ xenotransplantation products in humans: microbial safety as illustrated for porcine cytomegalovirus. Xenotransplantation 2022; 29 (06) e12783
  Google Scholar
• 72 Egerer S, Fiebig U, Kessler B. et al. Early weaning completely eliminates porcine cytomegalovirus from a newly established pig donor facility for xenotransplantation. Xenotransplantation 2018; 25 (04) e12449
  Google Scholar
• 73 Denner J, Tönjes RR. Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin Microbiol Rev 2012; 25 (02) 318-343
  Google Scholar
• 74 Halecker S, Krabben L, Kristiansen Y. et al. Rare isolation of human-tropic recombinant porcine endogenous retroviruses PERV-A/C from Göttingen minipigs. Virol J 2022; 19 (01) 30
  Google Scholar
• 75 Denner J, Schuurman HJ. High prevalence of recombinant porcine endogenous retroviruses (PERV-A/Cs) in minipigs: a review on origin and presence. Viruses 2021; 13 (09) 1869
  Google Scholar
• 76 Karlas A, Irgang M, Votteler J. et al. Characterisation of a human cell-adapted porcine endogenous retrovirus PERV-A/C. Ann Transplant 2010; 15 (02) 45-54
  Google Scholar
• 77 Denner J. Why was PERV not transmitted during preclinical and clinical xenotransplantation trials and after inoculation of animals?. Retrovirology 2018; 15 (01) 28
  Google Scholar
• 78 Entwistle JW, Sade RM, Drake DH. Clinical xenotransplantation seems close: Ethical issues persist. Artif Organs 2022; 46 (06) 987-994
  Google Scholar
• 79 Caplan A, Parent B. Ethics and the emerging use of pig organs for xenotransplantation. J Heart Lung Transplant 2022; 41 (09) 1204-1206
  Google Scholar
• 80 Johnson LSM. Existing ethical tensions in xenotransplantation. Camb Q Healthc Ethics 2022; 31 (03) 355-367
  Google Scholar
• 81 Silverman H, Odonkor PN. Reevaluating the ethical issues in porcine-to-human heart xenotransplantation. Hastings Cent Rep 2022; 52 (05) 32-42
  Google Scholar
• 82 Marckmann G, Schmidt H, Sofaer N, Strech D. Putting public health ethics into practice: a systematic framework. Front Public Health 2015; 3: 23
  Google Scholar
• 83 Cooper DKC, Keogh AM, Brink J. et al; Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant 2000; 19 (12) 1125-1165
  Google Scholar
• 84 Reichart B, Cooper DKC, Längin M, Tönjes RR, Pierson III RN, Wolf E. Cardiac xenotransplantation: from concept to clinic. Cardiovasc Res 2023; 118 (18) 3499-3516
  Google Scholar
• 85 Halecker S, Hansen S, Krabben L, Ebner F, Kaufer B, Denner J. How, where and when to screen for porcine cytomegalovirus (PCMV) in donor pigs for xenotransplantation. Sci Rep 2022; 12 (01) 21545
  Google Scholar
• 86 Kögel J, Thiersch S, Ludwig B, Seissler J, Marckmann G. What does it take to consent to islet cell xenotransplantation?: Insights from an interview study with type 1 diabetes patients and review of the literature. BMC Med Ethics 2021; 22 (01) 37
  Google Scholar
• 87 Pierson III RN, Allan JS, Cooper DKC. et al. Expert opinion special feature: patient selection for initial clinical trials of pig organ transplantation. Transplantation 2022; 106 (09) 1720-1723
  Google Scholar
• 88 Kögel J, Marckmann G. [First-of-its-kind xenotransplantation: need for ethical reflection in science and society]. Ethik Med 2023; 35 (01) 137-143
  Google Scholar
• 89 Marks P, Solomon S. Clarifying US regulations on xenotransplantation. Nat Biotechnol 2021; 39 (12) 1500-1501
  Google Scholar
• 90 Bleiweis MS, Philip J, Peek GJ. et al. Palliation plus ventricular assist device insertion in 15 neonates and infants with functionally univentricular circulation. Ann Thorac Surg 2022; 114 (04) 1412-1418
  Google Scholar
• 91 Philip J, Powers E, Machado D. et al. Pulsatile ventricular assist device as a bridge to transplant for the early high-risk single-ventricle physiology. J Thorac Cardiovasc Surg 2021; 162 (02) 405-413.e4
  Google Scholar
• 92 Rossano JW, VanderPluym CJ, Peng DM. et al; Pedimacs Investigators. Fifth Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report. Ann Thorac Surg 2021; 112 (06) 1763-1774
  Google Scholar
• 93 Chaban R, Cooper DKC, Pierson III RN. Pig heart and lung xenotransplantation: present status. J Heart Lung Transplant 2022; 41 (08) 1014-1022
  Google Scholar
• 94 Hundrieser J, Hein R, Pokoyski C. et al. Role of human and porcine MHC DRB1 alleles in determining the intensity of individual human anti-pig T-cell responses. Xenotransplantation 2019; 26 (04) e12523
  Google Scholar